亚洲精品国精品久久99热,91 禁,日本亚洲黄色

Montana Allows Drug Sales Post-Phase 1 Without FDA Approval FDA Montana Montana passes groundbreaking legislation allowing in-state sale of drugs after Phase 1 trials without FDA approval, aiming to boost experimental treatments and medical tourism.
Will Trump's Global Lowest Price Policy Work? Trump Trump's executive order to reduce U.S. drug prices by 30-80% has sparked debates and industry concerns. The policy aims to cut costs, but its feasibility and impact on global markets remain uncertain.
FDA Approvals Summary - April 2025 FDA Drug Approvals FDA Discover the FDA's new drug approvals in April 2025, including treatments for IgAN, nasopharyngeal carcinoma, myasthenia gravis, and colorectal cancer. Learn about groundbreaking therapies like Vanrafia, Penpulimab-KCQX, and Imaavy.
Final Ruling on Anti-Dumping Investigation of Cypermethrin from India Cypermethrin China's Ministry of Commerce announces final ruling on anti-dumping duties for cypermethrin from India, with tariffs up to 166.2% effective May 7, 2025, for five years.
Trump Signs Executive Order to Accelerate Domestic Drug Manufacturing FDA Trump EPA On May 5, Trump signed an executive order to simplify regulations and accelerate domestic pharmaceutical manufacturing, aiming to reduce U.S. dependence on foreign drug production.
FDA Layoffs Affect Drug Approvals, Forcing Pharma Companies to Exploit Loopholes FDA FDA Drug Approvals Market Trend Daré Bioscience FDA layoffs delay drug approvals, forcing Daré Bioscience to use regulatory loopholes to launch a female-use sildenafil cream, raising safety and oversight concerns.
New FDA Commissioner Takes Office FDA Market Trend New FDA Commissioner Martin A. Makary takes office, announcing major reforms targeting rare disease drug approvals, aiming to streamline processes and enhance post-market surveillance.
FDA's New Policy: Ban on Industry Employees as Advisors FDA The FDA bans employees of regulated companies from voting on advisory committees to reduce conflicts of interest, enhance transparency, and rebuild public trust under new reforms by Commissioner Makary.
EU Approves Upadacitinib for Treatment of Giant Cell Arteritis Upadacitinib EU Abbvie The EU has approved AbbVie's RINVOQ? (upadacitinib) 15mg daily for treating adult giant cell arteritis (GCA), marking the first approved oral JAK inhibitor for GCA in Europe.
FDA Approvals Summary - March 2025 FDA Drug Approvals FDA A summary of FDA drug approvals in March 2025, including new treatments for asthma, food allergies, osteoporosis, Prader-Willi syndrome, hemophilia, and more.

< Pre 123 4 5 6 Next >

News Archives

All Categories

Industry News Agricultural News Industrial News Cosmetic News Exhibition News Food News Science News Pharmaceutical News

永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a

Chemical Policy

HOT Topics